39872209|t|The role of ketamine and its enantiomer in managing depression and pain in cancer patients: A narrative review.
39872209|a|Depression and pain are common comorbidities in cancer patients, and ketamine, a dissociative anesthetic, has shown potential in managing both. This review summarizes current literature on ketamine and its enantiomer, esketamine, in managing depression and pain in the oncologic population. Studies indicate that sub-anesthetic doses of intravenous ketamine and esketamine can alleviate postoperative depressive symptoms in cancer patients with a tolerable safety profile. Research into non-intravenous routes for depression management in the oncologic population remains limited. Ketamine has also proven effective in managing acute postoperative pain, particularly through intravenous administration. While alternative administration routes, such as local infiltration and intramuscular methods, show mixed results, they may provide viable options for patients averse to intravenous (IV). However, the effectiveness of ketamine for chronic cancer pain remains inconsistent. Overall, ketamine offers a promising approach for managing depression and pain in oncologic patients.
39872209	12	20	ketamine	Chemical	-
39872209	52	62	depression	Disease	MESH:D003866
39872209	67	71	pain	Disease	MESH:D010146
39872209	75	81	cancer	Disease	MESH:D009369
39872209	82	90	patients	Species	9606
39872209	112	122	Depression	Disease	MESH:D003866
39872209	127	131	pain	Disease	MESH:D010146
39872209	160	166	cancer	Disease	MESH:D009369
39872209	167	175	patients	Species	9606
39872209	181	189	ketamine	Chemical	-
39872209	301	309	ketamine	Chemical	-
39872209	330	340	esketamine	Chemical	MESH:C000629870
39872209	354	364	depression	Disease	MESH:D003866
39872209	369	373	pain	Disease	MESH:D010146
39872209	381	390	oncologic	Disease	MESH:D000072716
39872209	461	469	ketamine	Chemical	-
39872209	474	484	esketamine	Chemical	MESH:C000629870
39872209	499	532	postoperative depressive symptoms	Disease	MESH:D003866
39872209	536	542	cancer	Disease	MESH:D009369
39872209	543	551	patients	Species	9606
39872209	626	636	depression	Disease	MESH:D003866
39872209	655	664	oncologic	Disease	MESH:D000072716
39872209	693	701	Ketamine	Chemical	MESH:D007649
39872209	746	764	postoperative pain	Disease	MESH:D010149
39872209	966	974	patients	Species	9606
39872209	1033	1041	ketamine	Chemical	-
39872209	1054	1065	cancer pain	Disease	MESH:D000072716
39872209	1097	1105	ketamine	Chemical	-
39872209	1147	1157	depression	Disease	MESH:D003866
39872209	1162	1166	pain	Disease	MESH:D010146
39872209	1170	1179	oncologic	Disease	MESH:D000072716
39872209	1180	1188	patients	Species	9606
39872209	Negative_Correlation	MESH:C000629870	MESH:D009369
39872209	Negative_Correlation	MESH:C000629870	MESH:D010146
39872209	Negative_Correlation	MESH:D007649	MESH:D010149
39872209	Negative_Correlation	MESH:C000629870	MESH:D003866

